+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

The 2022 World Market for Vaccines - Product Thumbnail Image

The 2022 World Market for Vaccines

  • Report
  • October 2022
  • 194 Pages
  • Global
From
From
From
Global Vaccines Market 2024-2028 - Product Thumbnail Image

Global Vaccines Market 2024-2028

  • Report
  • March 2024
  • 163 Pages
  • Global
From
Novel Vaccine Delivery Devices Market, 2019-2030 - Product Thumbnail Image

Novel Vaccine Delivery Devices Market, 2019-2030

  • Report
  • November 2019
  • 403 Pages
  • Global
From
Global Human Vaccine Market 2024-2028 - Product Thumbnail Image

Global Human Vaccine Market 2024-2028

  • Report
  • November 2023
  • 166 Pages
  • Global
From
Global Covid-19 Vaccination Market 2023-2027 - Product Thumbnail Image

Global Covid-19 Vaccination Market 2023-2027

  • Report
  • October 2023
  • 156 Pages
  • Global
From
Global Vaccine Research Market 2023-2027 - Product Thumbnail Image

Global Vaccine Research Market 2023-2027

  • Report
  • July 2023
  • 160 Pages
  • Global
From
Global Influenza Vaccine Market 2023-2027 - Product Thumbnail Image

Global Influenza Vaccine Market 2023-2027

  • Report
  • May 2023
  • 162 Pages
  • Global
From
From
From
Global Covid-19 Vaccine Market, Forecast to 2029 - Product Thumbnail Image

Global Covid-19 Vaccine Market, Forecast to 2029

  • Report
  • January 2022
  • 139 Pages
  • Global
From
From
From
From
Loading Indicator